Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05041244Not ApplicableCompleted

Negative Pressure Wound Therapy in Diabetic Wounds

Role: lead

NCT05027334Not ApplicableCompleted

Self-Management of Type-2 Diabetes Using a Mobile Application

Role: lead

NCT04314258Not ApplicableUnknown

Effect of Moringa Oleifera Infusion on Health

Role: lead

NCT01248143Phase 2Completed

Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases

Role: collaborator

NCT00114907Not ApplicableCompleted

Effects of Black Tea on Cardiovascular Disease in the Mauritian Population

Role: lead

All 5 trials loaded